In people with type 1 diabetes, the pancreas does not produce insulin
Most common adverse events at all doses: Nausea (3355%, dose-related) Vomiting (1335%) Decreased appetite (1528%) Constipation or diarrhea (1020%) Injection-site reaction (510%) Dose-related dysesthesia signal: The TRIUMPH-4 trial identified a dose-related dysesthesia (nerve-tingling, paresthesia) signal: This is the most-flagged trial-level safety signal for retatrutide and the reason community doses cluster at 2-4 mg/week well below where the dysesthesia signal becomes prominent
Marks MS, Seabra MC
These medications have revolutionized the management of these conditions and more, such as cardiovascular or renal disease, neurodegeneration, and cancer by offering significant improvements in glycemic control and promoting weight loss (Nathan et al
doi: 10.1210/jcem-41-6-1130 42 LiuYGongCLiJNingXZengPWangLet al
benefit is most reliably seen in patients with confirmed deficiencies [7, 11, 14, 15] Blood sugar dysregulation can impair inner ear circulation through the same endothelial mechanisms that cause diabetic complications Ginkgo biloba EGb 761 standardised extract may help certain tinnitus presentations